US 10913709
STAT3 inhibitor formulation
granted A61KA61K31/197A61K9/0053
Quick answer
US patent 10913709 (STAT3 inhibitor formulation) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/197, A61K9/0053, A61K9/08, A61P